Anti-cancer drugs

被引：2

作者：

Bergmann-Leitner, Elke ^{[1
]}

机构：

[1] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA

来源：

关键词：

D O I：

10.2174/138161208784246207

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1048 / 1048

页数：1

共 50 条

[1] Anti-cancer drugs
Bergmann-Leitner, ES
[J]. CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (09) : 1077 - 1078
[2] Anti-Cancer Drugs
Bergmann-Leitner, Elke
[J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (07) : 730 - 731
[3] Development of Anti-cancer Drugs
Arrondeau, Jennifer
Gan, Hui K.
Razak, Albiruni R. A.
Paoletti, Xavier
Le Tourneau, Christophe
[J]. DISCOVERY MEDICINE, 2010, 10 (53) : 355 - 362
[4] Teratogens as anti-cancer drugs
Blagosklonny, MV
[J]. CELL CYCLE, 2005, 4 (11) : 1518 - 1521
[5] Anti-cancer drugs for cardioprotection
Wu, Nan
Xie, Yizhen
Yang, Burton B.
[J]. CELL CYCLE, 2017, 16 (02) : 155 - 156
[6] HANDLING ANTI-CANCER DRUGS
不详
[J]. LANCET, 1983, 1 (8323): : 543 - 543
[7] TESTING ANTI-CANCER DRUGS
不详
[J]. LANCET, 1972, 1 (7755): : 827 - +
[8] TESTING ANTI-CANCER DRUGS
BERENBAUM, MC
SHEARD, CE
[J]. LANCET, 1972, 1 (7760): : 1116 - +
[9] Improved anti-cancer drugs
Barden, D
[J]. DALTON TRANSACTIONS, 2005, (11) : C42 - C42
[10] Improved anti-cancer drugs
Barden, D
[J]. CHEMISTRY WORLD, 2005, 2 (06): : 20 - 20